To include your compound in the COVID-19 Resource Center, submit it here.

Complement component C1q as a hepatitis-associated liver cancer target

DISEASE CATEGORY: Hepatic; cancer

INDICATION: Hepatitis; liver cancer

Inhibiting the complement component C1q could treat

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE